Search
Introduction On June 18, 2024, the Federal Trade Commission (“FTC”) unanimously agreed to submit a comment supporting a recent proposed U.S. Patent and Trademark Office (“PTO”) rule that would mandate the disclosure of all settlement agreements made between parties appearing before the Patent Trial...
On June 27, 2024, the Supreme Court released its highly anticipated opinion in Harrington v. Purdue Pharma L.P., Case No. 23-124. The question before the Court was whether the bankruptcy code authorizes a court to approve, as part of a chapter 11 plan, a release that extinguishes claims held by...
On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...